Bob D. Rush
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 5%
- Liver physiology and pathology
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 4
-
- Receptor Mechanisms and Signaling 4
- Protein Hydrolysis and Bioactive Peptides 2
- Co-authors
- Mary J. Ruwart (17 shared papers)Karen F. Wilkinson (11 shared papers)Thomas J. Vidmar (4 shared papers)Philip S. Burton (3 shared papers)Henry D. Appelman (2 shared papers)Keith S. Henley (2 shared papers)Gordon L. Bundy (1 shared paper)Jed F. Fisher (1 shared paper)
- Journals
- Pharmaceutical Research (6 papers)Hepatology (3 papers)Journal of Medicinal Chemistry (2 papers)Prostaglandins (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Bob D. Rush
21 papers receiving 649 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 153
- Hepatology 113
- Transplantation 20
- Oncology 155
- Pharmaceutical Science 36
Countries citing papers authored by Bob D. Rush
This map shows the geographic impact of Bob D. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob D. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob D. Rush more than expected).
Fields of papers citing papers by Bob D. Rush
This network shows the impact of papers produced by Bob D. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob D. Rush. The network helps show where Bob D. Rush may publish in the future.
Co-authors
The 25 scholars most cited alongside Bob D. Rush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 98 | |
| 2 | 1989 | 87 | |
| 3 | 1976 | 70 | |
| 4 | 2002 | 68 | |
| 5 | 1992 | 60 | |
| 6 | 1988 | 52 | |
| 7 | 1993 | 48 | |
| 8 | 1991 | 40 | |
| 9 | 1986 | 35 | |
| 10 | 1993 | 30 | |
| 11 | 1992 | 27 | |
| 12 | 1984 | 17 | |
| 13 | 1984 | 15 | |
| 14 | 1980 | 14 | |
| 15 | 1984 | 14 | |
| 16 | 2007 | 10 | |
| 17 | 1990 | 7 | |
| 18 | 1993 | 5 | |
| 19 | 1993 | 2 | |
| 20 | 1979 | 1 |
About Bob D. Rush
Bob D. Rush is a scholar working on Oncology, Molecular Biology, Cellular and Molecular Neuroscience, Infectious Diseases and Surgery, having authored 21 papers that have together received 701 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Receptor Mechanisms and Signaling (4 papers), Inflammatory mediators and NSAID effects (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), HIV/AIDS drug development and treatment (3 papers), Protein Hydrolysis and Bioactive Peptides (2 papers) and Renin-Angiotensin System Studies (2 papers). The work is most often cited by research in Pharmacology (153 citations), Hepatology (113 citations), Transplantation (20 citations), Oncology (155 citations) and Pharmaceutical Science (36 citations). Bob D. Rush has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Mary J. Ruwart, Karen F. Wilkinson, Thomas J. Vidmar, Philip S. Burton, Henry D. Appelman, Keith S. Henley, Gordon L. Bundy, Jed F. Fisher, Allen W. Harrison and D. G. McDevitt. Their work appears in journals such as Pharmaceutical Research, Hepatology, Journal of Medicinal Chemistry, Prostaglandins and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.